| answer text |
<p>Information on the number of patients on long-term Warfarin prescriptions who have
access to self-monitoring technology is not collected centrally.</p><p> </p><p> </p><p>
</p><p>NHS England and clinical commissioning groups (CCGs) have responsibility for
commissioned services for patients who receive anticoagulation treatments. It is for
individual CCGs to commission treatment and services for patients on anticoagulation
treatment or other medications which require monitoring, as they are best placed to
identify what is needed in their local areas.</p><p> </p><p> </p><p> </p><p>There
is guidance in place to support CCGs in planning services for patients who receive
anticoagulation treatments. Under its Diagnostics Assessment Programme, the National
Institute for Health and Care Excellence (NICE) has published guidance on self-monitoring
of anticoagulation treatments which is attached and also available at:</p><p> </p><p>
</p><p> </p><p><a href="http://www.nice.org.uk/guidance/dg14" target="_blank">http://www.nice.org.uk/guidance/dg14</a></p><p>
</p><p> </p><p> </p><p>NICE has also published quality standards on the management
and treatment of atrial fibrillation which set out that self-monitoring should be
offered as an option to appropriate patients. The guidance is also attached and available
at:</p><p> </p><p> </p><p> </p><p><a href="http://www.nice.org.uk/guidance/qs93/chapter/Quality-statement-6-developmental-Selfmonitoring-of-anticoagulation"
target="_blank">http://www.nice.org.uk/guidance/qs93/chapter/Quality-statement-6-developmental-Selfmonitoring-of-anticoagulation</a></p><p>
</p>
|
|
